Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2026-01-02 @ 4:19 PM
Study NCT ID:
NCT01271868
Status:
TERMINATED
Last Update Posted:
2021-03-15
First Post:
2011-01-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Sponsor:
Medexus Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IB1001-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None